What Catalysts Could Shift the Narrative for Doximity Amid Analyst Debate? [Yahoo! Finance]
Doximity, Inc. Class A (DOCS)
Company Research
Source: Yahoo! Finance
to $71.11 per share following the most recent updates from Wall Street. This shift comes amid ongoing debate between analysts, with some seeing improved fundamentals and strategic advances driving long-term growth. Others remain cautious due to market uncertainties. Stay tuned to discover practical ways to track Doximity's evolving story and stay ahead of shifting sentiment. Stay updated as the Fair Value for Doximity shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on Doximity. What Wall Street Has Been Saying ?? Bullish Takeaways BofA upgraded Doximity to Buy from Neutral and raised their price target significantly to $82 from $75, citing the company's strategic pivot toward serving healthcare professionals as a key growth driver through 2026. BofA believes that FDA reforms to direct-to-consumer advertising are benefitting Doximity, as pharmaceutical manufacturers reallocate their marketing spend toward
Show less
Read more
Impact Snapshot
Event Time:
DOCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DOCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DOCS alerts
High impacting Doximity, Inc. Class A news events
Weekly update
A roundup of the hottest topics
DOCS
News
- Doximity (DOCS) Q2 2026 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Why Is Doximity (DOCS) Stock Soaring Today [Yahoo! Finance]Yahoo! Finance
- Doximity (NASDAQ:DOCS) was upgraded by analysts at Raymond James Financial, Inc. from an "outperform" rating to a "strong-buy" rating.MarketBeat
- Doximity (DOCS): A Closer Look at Valuation Following Recent Share Price Volatility [Yahoo! Finance]Yahoo! Finance
- Jim Cramer Says Doximity is “Still Too Expensive” [Yahoo! Finance]Yahoo! Finance
DOCS
Earnings
- 11/6/25 - Beat
DOCS
Sec Filings
- 12/3/25 - Form 4
- 12/1/25 - Form 144
- 11/24/25 - Form 4
- DOCS's page on the SEC website